PsychoGenics Inc. Achieves Another Milestone In Its Drug Discovery Collaboration With Sunovion
5/12/2014 8:47:49 AM
TARRYTOWN, N.Y.--(BUSINESS WIRE)--PGI Drug Discovery LLC (PsychoGenics), today announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to identify a new generation of treatments for neuropsychiatric disorders.
Help employers find you! Check out all the jobs and post your resume.
comments powered by